The mitogenic effect of bradykinin mediated by G protein-coupled B2Rs involving MEK/MAPK is observed in epithelial breast cancer cells [35], bovine tracheal smooth muscle cells [36], and also human renal carcinoma A498 cells [37]. This evidence concerns the gene MAP2K7 and renal carcinoma.